In this debate, members have raised the matter of continuous improvement in the COVID response, particularly in the area of technology. I want to touch, in my time remaining, on a few areas where technology has led to significant improvements in our COVID-19 response—firstly, in the realm of whole-genome sequencing. During this last case, this has allowed us to identify the so-called UK variant—or B.1.1.7. It has also enabled us to exclude the link to other cases in MIQ. This has been a huge development that I know members of the infectious diseases community have wanted for a long time, and it's excellent that it was able to be brought forward as part of the COVID response. I'm aware the workers in our whole-genome sequencing laboratories often work through the night to make sure we can find out if we have a link to a known case or if it is a case of unrecognised community transmission.